Home / Inspections / 1220695

FDA Inspection 1220695 — Phillip C. Williamson, Ph.D.

Phillip C. Williamson, Ph.D. — FEI 3011477346

The FDA completed an inspection of Phillip C. Williamson, Ph.D. on October 5, 2023 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 5, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Tempe, AZ (United States)

Additional Details

Clinical Investigator (CI)

Facility

Other inspections at this facility

  • 1222040 (NAI Fri Oct 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1220685 (NAI Fri Oct 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1202263 (NAI Thu Apr 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996289 (NAI Mon Dec 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927631 (NAI Wed May 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources